Evolent Health

Evolent administers specialty care management programs that cover oncology, cardiovascular disease, musculoskeletal disorders, and diagnostic imaging. The firm provides clinical pathways, decision support tools, provider and patient engagement services, and operates an ACO for independent providers. Its cancer program includes a member navigation service that pairs personalized support with a digital platform.

Evolent employs nearly 400 physicians and 750 nurses globally, positioning clinical labor as a core operational asset rather than an outsourced function. That workforce maintains the firm's clinical pathways, engages treating providers, and staffs its member navigation and decision support programs across multiple specialties.

No. Evolent contracts with health plans to manage specialty care, but it does not underwrite insurance risk, bill patients directly, or operate treatment facilities. It functions as a clinically staffed intermediary, inserting governance and pathway adherence protocols between payer reimbursement and specialist treatment decisions.

The Scientific Advisory Board comprises academic and community-based specialist physicians who review and update Evolent's clinical pathways. The panel is designed to ensure that treatment guidance reflects current evidence and frontline clinical perspectives, which in turn supports provider acceptance of pathway recommendations when Evolent engages treating physicians.

Evolent's disclosed programs cover oncology, cardiovascular disease, musculoskeletal disorders, and diagnostic imaging. Within those categories, its solutions address cancer care navigation, high-value surgical and pain management decisions, ACO performance for independent providers, and radiation safety in imaging.